Physician profile
Walter Berkowitz
NPI 1538165469
$1,284.79
in general payments reported to CMS, 2019-2025
21 companies · $57.07 in 2025
The $57.07 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $147 · 2021: $30.09 · 2022: $34.25 · 2023: $52.31 · 2024: $158 · 2025: $57.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $350.76 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $155.00 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $133.41 | 2019 | |
| Sanofi-Aventis U.S. LLC | $122.99 | 2019 | |
| Boston Scientific Corporation | $75.21 | 2019-2022 | |
| Amgen INC. | $74.62 | 2019-2020 | |
| Vifor Pharma, INC. | $49.90 | 2019-2021 | |
| Atricure, INC. | $48.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.97 | 2019-2020 | |
| Pfizer INC. | $28.19 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.82 | 2019 | |
| Gilead Sciences, INC. | $26.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.58 | 2019 | |
| Portola Pharmaceuticals, LLC | $22.87 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.00 | 2021 | |
| Amarin Pharma, INC. | $16.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.64 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $14.47 | 2019 | |
| Lundbeck LLC | $12.25 | 2020 | |
| Medicure Pharma INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Berkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.